Cynata Therapeutics has an EPS of $-0.0984. In 2022, the company made an earnings per share (EPS) of $-0.038. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.0984 | 158.95% |
2022 | -$0.038 | -35.59% |
2021 | -$0.059 | 70.05% |
2020 | -$0.034696 | - |